Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy
Author(s) -
Rohit Srivastava,
Medhavi Agarwal,
Ashish Pundhir
Publication year - 2011
Publication title -
case reports in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.17
H-Index - 4
eISSN - 2090-682X
pISSN - 2090-6838
DOI - 10.1155/2011/563204
Subject(s) - donepezil , autism , medicine , psychiatry , cognition , pediatrics , dementia , disease
A woman consulted psychiatric Out-Patient Department (OPD) for her 5-year and 2-month-old son presenting with typical autistic symptoms like social, behavioural, and communicational ineptitudeness. Subsequent treatment with Donepezil resulted in marked improvement in the aforementioned symptomatology. Recent studies in autistic child have shown diminished acetylcholine and nicotinic receptor activity, thus an acetylcholinergic enhancer, Donepezil, likely accounts for improvement in autistic symptoms. Evidently, the case report consolidates Donepezil role as a potentially useful agent in the treatment of cognitive and behavioural symptoms observed in this disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom